Site icon Market Globalist

What Caused BCTX Stock To Rise By Almost 19% On Friday?

Best Drone Stocks

Best Drone Stocks

The previous market close for BriaCell Therapeutics Corp. (NASDAQ:BCTX) was up 18.95% at $5.21, with volume reaching 7.04 million shares. In contrast, BriaCell stock average daily volume stands at 383.89K.

There are 5.62M shares outstanding for BCTX stock and its current market value sits at $29.30M. BCTX stock surged despite lacking any current news, but may be gaining traction as a result of its participation in cancer research event.

Read More

What will BCTX are presenting?

BriaCell is a biotechnology company focused on immuno-oncology developing highly effective cancer-management approaches. Oncologists are increasingly turning to immunotherapies to treat cancer due to the possibility of a lowered risk and possibility for fewer side effects than chemotherapy, as well possible prevention of recurrence of the disease. With the goal of making breast cancer care more accessible to women with limited therapy options, BriaCell has been committed to developing novel immunotherapies to fight cancer.

Recently, BriaCell announced that it had been shortlisted for a presentation at the American Association for Cancer Research (AACR) Annual Meeting in 2021.

More from BCTX:

A number of BriaCell (BCTX) executives, directors, officers, employees and consultants have also been granted 617,300 number of incentive stock options as part of the BCTX’s stock option plan. Stock Options will vest immediately, will expire in 5 years, and will be exercisable at a price of $4.24 per common share in the capital of BCTX. Currently, BCTX has 635,352 outstanding Stock Options as a result of the Stock Option Grant.

Exit mobile version